Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study.
Saved in:
| Title: | Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. |
|---|---|
| Authors: | Harrison SA; Hepatology, Radcliffe Department of Medicine, University of Oxford, UK. Electronic address: sharrison@pinnacleresearch.com., Alkhouri N; Texas Liver Institute, San Antonio, TX, USA., Davison BA; Momentum Research, Inc., Durham, NC, USA., Sanyal A; Virginia Commonwealth University School of Medicine, Richmond, VR, USA., Edwards C; Momentum Research, Inc., Durham, NC, USA., Colca JR; Cirius Therapeutics, Inc., San Diego, CA, USA., Lee BH; Cirius Therapeutics, Inc., San Diego, CA, USA., Loomba R; NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA., Cusi K; University of Florida, Gainesville, FL, USA., Kolterman O; Pendulum Therapeutics, San Francisco, CA, USA., Cotter G; Momentum Research, Inc., Durham, NC, USA., Dittrich HC; Cirius Therapeutics, Inc., San Diego, CA, USA. |
| Source: | Journal of hepatology [J Hepatol] 2020 Apr; Vol. 72 (4), pp. 613-626. Date of Electronic Publication: 2019 Nov 04. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
